A Case of Docetaxel Induced Subacute Cutaneous Lupus Erythematosus.
10.4046/trd.2009.66.5.380
- Author:
Jung Ar SHIN
1
;
Chul Woong HUH
;
Ji Eun KWON
;
Hyung Jung KIM
;
Chul Min AHN
;
Yoon Soo CHANG
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. yschang@yuhs.ac
- Publication Type:Case Report
- Keywords:
Subacute cutaneous lupus erythematosus;
Drug-induced lupus erythematosus;
Non-small-cell lung carcinoma;
Docetaxel
- MeSH:
Adrenal Cortex Hormones;
Antihypertensive Agents;
Basement Membrane;
Biopsy;
Carcinoma, Non-Small-Cell Lung;
Cisplatin;
Dermatitis;
Female;
Humans;
Immunoglobulin M;
Lupus Erythematosus, Cutaneous;
Middle Aged;
Skin;
Taxoids
- From:Tuberculosis and Respiratory Diseases
2009;66(5):380-384
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is associated with use of the following classes of medications: anti-hypertensives, anti-cholesterolemia, anti-psychotics, and anti-inflammatory drugs. Docetaxel is an anti-neoplastic agent, which is widely used for treatment of non-small cell lung cancer. Few cases of docetaxel-induced SCLE have been reported in the medical literature. Here, we report the case of a 58-year-old female patient who developed drug-induced SCLE after administration of docetaxel. After 4 cycles of chemotherapy with docetaxel and cisplatin, erythematous skin eruptions developed on the patient's face. Skin biopsies of the eruptions were remarkable for interfacing dermatitis with basement membrane thickening. Immunofluorescent study revealed characteristic features of SCLE, including granular deposition of IgM, C3, and apoptotic bodies along the basement membrane. The skin eruptions resolved gradually after cessation of drug and with the use of topical corticosteroids.
